People moves: Biopharma finance & accounting
George Eldridge was appointed chief financial officer of Abcuro, a clinical-stage biotech developing therapies for the treatment of autoimmune diseases...
George Eldridge was appointed chief financial officer of Abcuro, a clinical-stage biotech developing therapies for the treatment of autoimmune diseases...